Prenatal diagnosis of genetic diseases directly using paper-dried cord blood as the starting material for PCR
A rapid and low-cost method of diagnosis is becoming important for detecting fetal inherited diseases, including single-gene disorders and chromosomal abnormalities. Here, we demonstrated an innovation that use paper-dried cord blood (PCB) as the starting material for PCR and whole genome amplification without any DNA extraction step at a very low cost. A novel PCR buffer named “DDB buffer” containing ammonium sulfate and glycerol were used instead of the conventional 10× PCR buffer. The amplicons were directly analyzed through microchip electrophoresis and whole genome sequencing. Inhibitory substances in filter paper were effectively inactivated using DDB buffer. Direct PCR amplification of DNA fragments ranging from 100 to 900 bp using filter paper spotted with 0.5 to 5 μL of cord blood and various anticoagulants was successful. We were able to determine fetal single-gene disorders and chromosomal diseases in all 46 chromosomes using PCB samples successfully. Compared with prenatal diagnosis using purified DNA, the proposed method is simple, fast, less prone to cross-contamination at minimal cost. Researchers and clinical and healthcare workers may employ this method for genetic diagnosis using cord blood samples with minimum laboratory resources. This method is very promising for a variety of genetic diagnosis applications in underserved communities at the point of need in developing areas.
KeywordsDirect PCR Paper-dried cord blood Prenatal diagnosis Single-gene disorders Chromosomal abnormalities
Collagen type 1 alpha 2
Duchenne muscular dystrophy
Paper-dried cord blood
Polymerase chain reaction
Survival of motor neuron 1
This work was supported by the National Natural Science Foundation of China (81741040), Medical Talent of Empowering Medicine through Science and Education Program (QNRC2016618), the Key Provincial Talents of Maternal and Child Health Program in Jiangsu Province (FRC2017-43), and the project for the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX10231802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
- 6.Xiao H, Yang YL, Zhang CY, Liao EJ, Zhao HR, Liao SX. Karyotype analysis with amniotic fluid in 12365 pregnant women with indications for genetic amniocentesis and strategies of prenatal diagnosis. J Obstet Gynaecol. 2016;36(3):293–6. https://doi.org/10.3109/01443615.2015.1041889.CrossRefPubMedGoogle Scholar
- 10.Brison N, Van Den Bogaert K, Dehaspe L, van den Oever JM, Janssens K, Blaumeiser B, et al. Accuracy and clinical value of maternal incidental findings during noninvasive prenatal testing for fetal aneuploidies. Genet Med. 2017;19(3):306–13. https://doi.org/10.1038/gim.2016.113.CrossRefPubMedGoogle Scholar
- 15.Srebniak MI, Knapen M, Polak M, Joosten M, Diderich KEM, Govaerts LCP, et al. The influence of SNP-based chromosomal microarray and NIPT on the diagnostic yield in 10,000 fetuses with and without fetal ultrasound anomalies. Hum Mutat. 2017;38(7):880–8. https://doi.org/10.1002/humu.23232.CrossRefPubMedGoogle Scholar
- 18.Orhant L, Anselem O, Fradin M, Becker PH, Beugnet C, Deburgrave N, et al. Droplet digital PCR combined with minisequencing, a new approach to analyze fetal DNA from maternal blood: application to the non-invasive prenatal diagnosis of achondroplasia. Prenat Diagn. 2016;36(5):397–406. https://doi.org/10.1002/pd.4790.CrossRefPubMedGoogle Scholar
- 22.Gemperle-Britschgi C, Iorgulescu D, Mager MA, Anton-Paduraru D, Vulturar R, Thony B. A novel common large genomic deletion and two new missense mutations identified in the Romanian phenylketonuria population. Gene. 2016;576:182–8. https://doi.org/10.1016/j.gene.2015.10.020.CrossRefPubMedGoogle Scholar
- 23.Aldamiz-Echevarria L, Llarena M, Bueno MA, Dalmau J, Vitoria I, Fernandez-Marmiesse A, et al. Molecular epidemiology, genotype-phenotype correlation and BH4 responsiveness in Spanish patients with phenylketonuria. J Hum Genet. 2016;61(8):731–44. https://doi.org/10.1038/jhg.2016.38.CrossRefPubMedGoogle Scholar
- 24.Kosuga M, Mashima R, Hirakiyama A, Fuji N, Kumagai T, Seo JH, et al. Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: genetic, pathological, and structural studies on iduronate-2-sulfatase. Mol Genet Metab. 2016;118(3):190–7. https://doi.org/10.1016/j.ymgme.2016.05.003.CrossRefPubMedGoogle Scholar
- 25.Brusius-Facchin AC, Abrahao L, Schwartz IV, Lourenco CM, Santos ES, Zanetti A, et al. Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence. Gene. 2013;526(2):150–4. https://doi.org/10.1016/j.gene.2013.05.007.CrossRefPubMedGoogle Scholar
- 28.Kou HS, Wang CC. Molecular inversion probes equipped with discontinuous rolling cycle amplification for targeting nucleotide variants: determining SMN1 and SMN2 genes in diagnosis of spinal muscular atrophy. Anal Chim Acta. 2017;977:65–73. https://doi.org/10.1016/j.aca.2017.04.037.CrossRefPubMedGoogle Scholar
- 29.Taylor JL, Lee FK, Yazdanpanah GK, Staropoli JF, Liu M, Carulli JP, et al. Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency. Clin Chem. 2015;61(2):412–9. https://doi.org/10.1373/clinchem.2014.231019.CrossRefPubMedGoogle Scholar
- 30.Liu S, Song L, Cram DS, Xiong L, Wang K, Wu R, et al. Traditional karyotyping vs copy number variation sequencing for detection of chromosomal abnormalities associated with spontaneous miscarriage. Ultrasound Obstet Gynecol. 2015;46(4):472–7. https://doi.org/10.1002/uog.14849.CrossRefPubMedGoogle Scholar
- 35.Al-Soud WA, Jonsson LJ, Radstrom P. Identification and characterization of immunoglobulin G in blood as a major inhibitor of diagnostic PCR. J Clin Microbiol. 2000;38(1):345–50 https://eurekamag.com/research/010/779/010779586.php.PubMedPubMedCentralGoogle Scholar